Sabra Healthcare REIT (NASDAQ:SBRA) Rating Increased to Buy at Truist Financial

Posted by Brenda Bartman on Jul 8th, 2026

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) was upgraded by equities researchers at Truist Financial from a “hold” rating to a “buy” rating in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a $22.00 target price on the real estate investment trust’s stock. Truist Financial’s target price would suggest a potential upside of 9.67% from the stock’s previous close.

SBRA has been the topic of a number of other reports. UBS Group set a $19.00 price target on Sabra Healthcare REIT in a report on Thursday, June 18th. Citigroup downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $24.00 to $19.00 in a report on Monday, June 22nd. Scotiabank decreased their target price on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Wells Fargo & Company boosted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Finally, Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Six research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $21.27.

View Our Latest Research Report on Sabra Healthcare REIT

Sabra Healthcare REIT Stock Performance

SBRA opened at $20.06 on Wednesday. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The business’s 50 day moving average is $19.70 and its 200-day moving average is $19.68. The stock has a market cap of $5.06 billion, a PE ratio of 31.84, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Institutional Trading of Sabra Healthcare REIT

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Principal Financial Group Inc. grew its holdings in shares of Sabra Healthcare REIT by 21.6% in the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after acquiring an additional 4,431,897 shares during the last quarter. Lasalle Investment Management Securities LLC purchased a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at $66,938,000. Norges Bank acquired a new position in shares of Sabra Healthcare REIT in the 4th quarter valued at $57,945,000. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Sabra Healthcare REIT by 1,019.8% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after purchasing an additional 2,736,993 shares during the period. Finally, Balyasny Asset Management L.P. purchased a new position in Sabra Healthcare REIT in the 2nd quarter worth about $49,955,000. 99.40% of the stock is currently owned by institutional investors.

About Sabra Healthcare REIT

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.